Concepedia

Marion Dorsch

MD

60

Publications

7.9K

Citations

40

H-Index

1991

Active since

Affiliations

Agios Pharmaceuticals (United States)(Current)

Millennium Engineering and Integration (United States)

Novartis (United States)

Blueprint Medicines (United States)

Freie Universität Berlin

Marion Dorsch is an author at Agios Pharmaceuticals (United States) specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

1991–2024

60

Publications

60

Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation

Fang Wang, Jeremy Travins, Byron DeLaBarre et al. · Science · 2013 · 789 citations

Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

Silvia Buonamici, Juliet Williams, Michael Morrissey et al. · Science Translational Medicine · 2010 · 553 citations

Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor

Sauveur-Michel Maira, Sabina Pecchi, Alan Huang et al. · Molecular Cancer Therapeutics · 2011 · 524 citations

, , +26

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate

Lukas Bunse, Stefan Pusch, Theresa Bunse et al. · Nature Medicine · 2018 · 515 citations

, , +9

A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture <i>In vitro</i>

Vincent C. Daniel, Luigi Marchionni, Jared S. Hierman et al. · Cancer Research · 2009 · 476 citations · Full text

Rows per page

1–5 of 60